Skip to main content
. 2024 Nov 30;61(4):345–350. doi: 10.29399/npa.28642

Table 2.

Clinical syndrome, neuroradiologic features and etiology of patients

Stroke cases with Covid-19 (N=21)(n, percent) Control stroke cases N=104(n, percent) p
Clinical syndrome p>0.05 for all subgroups
 LACS 2 (9%.5) 22 (21%.5)
 PACS 10 (47%.6) 37 (35%.8)
 POCS 4 (19%.4) 25 (24%)
 TACS 5 (23%.8.6) 20 (19%.2)
Infarct localisation p>0.05 for all subgroups
 ACA 2 (10%) 3 (3%)
 MCA 8 (40%) 45 (45%)
 VA-PICA 1 (5%) 8 (8%.2)
 Basilar 0 5 (5%.1)
 PCA 1 (5%) 15 (15%.3)
 Watershed 1 (5%) 1 (1%)
 Multiple-artery 6 (30%) 20 (20%.4)
 Not well-defined 1 (5%) 1 (1%)
Etiology p>0.05 for all subgroups
 LAA 8 (40%) 23 (23%.5)
 Cardioembolism 4 (20%) 36 (36%.7)
 Small vessel disease 0 1 (1%)
 Unknown 5 (25%) 17 (17%.3)
 Multiple 1 (5%) 15 (15%.3)
 Rare etiologies 2 (6%) 6 (6%.1)
Asymptomatic infarction 5 (23%.8) 19 (18%.6) 0.58
Asymptomatic vascular lesion 4 (19%) 13 (13%.5) 0.51
Hemorrhagic transformation 6 (30%) 11 (10%) 0.02
Anterior-posterior vascular system 0.02
 Anterior 12 (60%) 59 (60%.2)
 Posterior 5 (25%) 37 (37%.8)
 Anterior and posterior* 3 (15%) 2 (2%)

ACA: anterior cerebral artery; LAA: large artery atherosclerosis; LACS: lacunar syndrome; MCA: middle cerebral artery; PACS: partial anterior circulation syndrome; PCA: posterior cerebral artery; POCS: posterior circulation syndrome; TACS: total anterior circulation syndrome; VA-PICA: vertebral artery and posterior inferior cerebellar artery.